Global /Taiwan /Healthcare /Drug Manufacturers - General /7762

Pet Pharm Biotech Co., Ltd.

7762

• TPEX: 7762 • Delayed

49.55TWD -0.2%

1.58 USD

As of 5 June 2026, Pet Pharm Biotech Co., Ltd. has a market cap of $90.15M USD, ranking #26303 globally and #1461 in Taiwan. It ranks #2359 in the Healthcare sector, and #851 in the Drug Manufacturers - General industry.

Global Rank

26303

Country Rank

1461

Sector Rank

2359

Industry Rank

851

Key Stats

Market Cap

$90.15MUSD

2.84B TWD

Enterprise Value

$77.72MUSD

2.44B TWD

Revenue (TTM)

$7.06MUSD

222.03M TWD

EBITDA (TTM)

$1.21MUSD

38.19M TWD

Net Income (TTM)

$794.26KUSD

24.99M TWD

EBITDA Margin

17%

Profit Margin

11%

PE Ratio

107.7

PS Ratio

12.8

PB Ratio

2.4

EV/EBITDA

51.2

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Liang-Guang Lin open_in_new

Employees

Founded

2011

Website

petpharmbio.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.2%	-6.9%	0.4%	-27%	-37%	-29%	-11%	59%	59%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	7762 吉晟生技股份有限公司 ISIN: TW0007762007 Shares Out.: Shares Outstanding: 57.233M¹ TV: TradingView: TPEX: 7762 SA: Stock Analysis: TPEX: 7762 YF: Yahoo Finance: 7762.TWO GF: Google Finance: TPEX: 7762 BA: Barron's: 7762 MS: Morningstar: ROCO: 7762	49.55 TWD	TV: TradingView: TPEX: 7762 SA: Stock Analysis: TPEX: 7762 YF: Yahoo Finance: 7762.TWO GF: Google Finance: TPEX: 7762 BA: Barron's: 7762 MS: Morningstar: ROCO: 7762

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Pet Pharm Biotech Co., Ltd.

Pet Pharm Biotech Co., Ltd. manufactures and sells pharmaceutical products. The company also engages in the research, development, and production of nuclear medicine drugs. Its products include FDG fluodeoxyglucose, naolixi, and sodium fluoride injections; and radioactive sodium iodide capsules. The company was founded in 2011 and is based in New Taipei City, Taiwan.

Similar Companies

Industry: Drug Manufacturers - General (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
PharmaEssentia Corp. TWSE: 6446	$7.8B 245.34B TWD 9K%	48.6	Taiwan
Lotus Pharmaceutical Co., Ltd. TWSE: 1795	$1.84B 57.95B TWD 2K%	12.2	Taiwan
Center Laboratories, Inc. TPEX: 4123	$925.55M 29.11B TWD 927%	3.4	Taiwan
Lumosa Therapeutics Co., Ltd. TPEX: 6535	$809.3M 25.46B TWD 798%	-	Taiwan
Oneness Biotech Co., Ltd. TPEX: 4743	$789.12M 24.82B TWD 775%	-	Taiwan
TTY Biopharm Company Ltd. TPEX: 4105	$584.14M 18.38B TWD 548%	11.8	Taiwan

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 845K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 607K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 400K%	97.4	United States
Roche Holding AG SIX: RO	$323.4B 256.25B CHF 359K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.25B 215.59B GBP 321K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$276.26B 218.9B CHF 306K%	20.5	Switzerland

chevron_leftBack